Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

A-listers and wellness influencers have been buzzing about the supposed longevity-boosting chemical compound. Here’s how it works ...

Over the last two decades, scientific attention has increasingly shifted toward understanding how cellular energy system ...

CHICAGO, IL AND FORT WORTH, TX / ACCESS Newswire / March 24, 2026 / Actuate Therapeutics, Inc. (NASDAQ:ACTU) is a clinical-stage biopharmaceutical company advancing elraglusib, a first-in-class, ...

That distinction is the most important conversation business leaders aren’t having. Nature optimizes for survival. Most ...

The Medal of Honor is presented to individuals whose research has fundamentally advanced cancer prevention, diagnosis, treatment, and survivorship.

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats that consumers should understand.

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced the publication of abstracts for three poster presentations at the American Association for ...

Genetic research across multiple studies now points to a clear pattern: populations living in the Andes highlands for thousands of years carry distinct DNA variants that help their bodies cope with ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Inequities in science affect who can publish, access funding, and drive innovation. Hear from global experts as they discuss the challenges facing the worldwide scientific community.